GOODWILL AND OTHER INTANGIBLES (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Changes in the Carrying Amount of Goodwill

Changes in the carrying amounts of our goodwill for the years ended December 31, 2022 and December 31, 2021 were as follows (in thousands):

	Branded Pharmaceuticals		Sterile Injectables		Generic Pharmaceuticals		International Pharmaceuticals		Total
Goodwill as of December 31, 2020	$	828,818	$	2,731,193	$	—	$	—	$	3,560,011
Goodwill impairment charges	—		(363,000)		—		—		(363,000)
Goodwill as of December 31, 2021	$	828,818	$	2,368,193	$	—	$	—	$	3,197,011
Goodwill impairment charges	—		(1,845,000)		—		—		(1,845,000)
Goodwill as of December 31, 2022	$	828,818	$	523,193	$	—	$	—	$	1,352,011

The carrying amounts of goodwill at December 31, 2022 and December 31, 2021 are net of the following accumulated impairments (in thousands):

	Branded Pharmaceuticals		Sterile Injectables		Generic Pharmaceuticals		International Pharmaceuticals		Total
Accumulated impairment losses as of December 31, 2021	$	855,810	$	363,000	$	3,142,657	$	550,355	$	4,911,822
Accumulated impairment losses as of December 31, 2022	$	855,810	$	2,208,000	$	3,142,657	$	513,211	$	6,719,678

Schedule of Other Intangible Assets

Changes in the amounts of other intangible assets for the year ended December 31, 2022 are set forth in the table below (in thousands).

Cost basis:	Balance as of December 31, 2021		Acquisitions		Impairments		Effect of Currency Translation		Balance as of December 31, 2022
Licenses (weighted average life of 14 years)	$	442,107	$	—	$	—	$	—	$	442,107
Tradenames	6,409		—		—		—		6,409
Developed technology (weighted average life of 12 years)	6,226,139		—		(288,701)		(17,417)		5,920,021
Total other intangibles (weighted average life of 12 years)	$	6,674,655	$	—	$	(288,701)	$	(17,417)	$	6,368,537
Accumulated amortization:	Balance as of December 31, 2021		Amortization		Impairments		Effect of Currency Translation		Balance as of December 31, 2022
Licenses	$	(419,932)	$	(4,576)	$	—	$	—	$	(424,508)
Tradenames	(6,409)		—		—		—		(6,409)
Developed technology	(3,885,491)		(332,735)		—		13,541		(4,204,685)
Total other intangibles	$	(4,311,832)	$	(337,311)	$	—	$	13,541	$	(4,635,602)
Net other intangibles	$	2,362,823							$	1,732,935

Schedule of Future Amortization Expense

For intangible assets subject to amortization, estimated amortization expense for the five fiscal years subsequent to December 31, 2022 is as follows (in thousands):

2023	$	255,869
2024	$	245,751
2025	$	232,668
2026	$	209,532
2027	$	134,364